Please use this identifier to cite or link to this item:
|Title:||Comment on : Zhu et al. Fasting Plasma Glucose at 24–28 Weeks to Screen for Gestational Diabetes Mellitus : New Evidence From China. Diabetes Care 2013; 36:2038–2040|
Karamanos, Basil G.
|Keywords:||Evidence-based medicine -- China|
Diabetes -- Research
|Publisher:||American Diabetes Association|
|Citation:||Savona-Ventura, C., Vassallo, J., Marre, M., Karamanos, B. G., & MGSD-GDM Study Group. (2013). Comment on: Zhu et al. Fasting plasma glucose at 24–28 weeks to screen for gestational diabetes mellitus: new evidence from China. Diabetes care 2013; 36: 2038–2040. Diabetes Care, 36(9), e165-e165.|
|Abstract:||The article by Zhu et al. published inDiabetes Care concludes that a fasting plasma glucose (FPG) at 24–28 weeks’ gestation can be used in low-resource regions as a screening test to identify gestational diabetes mellitus (GDM) in Chinese patients. However, in their experience, a screening protocol using FPG cutoff points of $4.4 and #5.0 mmol/L would fail to identify about 12% of the GDM cases and require a formal oral glucose tolerance test (OGTT) to be performed in about half of the pregnant population. These observations contrast with our findings in a circum-Mediterranean population.|
|Appears in Collections:||Scholarly Works - FacM&SOG|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.